Wuhan YZY Biopharma

Wuhan YZY Biopharma is a leading biotechnology company. Our vision is to develop new class of innovative medicines based on breakthrough discovery in molecular biology . Our company is committed to anti-tumor bispecific antibody development, of which two bispecific antibodies have been submitted IND application in China, and several innovative drugs are in pre-clinical stage. As our scientists continue to investigate molecular disease targets to impact a broad range of human cancer, the possibility of targeting these previously "undruggable" targets with Bispecific antibodies, is coming true and becoming part of new drug discovery. Our goal is to minimize tumor hazard to promote human health! 

Phone:+86 27 82668988
OUR SCIENCE & TECHNOLOGY
The immune system is naturally programmed to seek out and destroy abnormal cells. Cancer is believed to thrive because of a number of cellular mechanisms that aid in the evasion of immune response. Immuno-oncology agents are rapidly emerging as a potential therapy.
A bi-specific monoclonal antibody (BsMAb) is an artificial antibody by hybrid of two different mAbs and is able to simultaneously bind to two different types of antigens or epitops. Wuhan YZY Biopharma has developed a non-symatric BsAb called YBODY®with one arm binding to cancer cell surface protein and the other arm binding to CD3 on T-cells.

Adoptive immune cell therapy represents an emerging and promising modality for the treatment of both infectious disease and cancer, YZY Biopharma’s proprietary technology can help old generation of cell immune therapy like CIK, NK cells convert to ‘target therapy’.

News Center
News! Bispecific antibody plat...

Recently, core patent BISPECIFIC ANTIBODY (Patent No.: US9562110) of bispecific antibody platform t...

02-23more
Another Core Patent For Bispec...

February 2017 – Wuhan YZY Biophama's another core technology patent is granted by the United States...

02-10more
Congratulation: YZYBIO bi-anti...

Recently, there is a good news in our WuHan YZY biopharmaceutical co.LTD. The application for expan...

07-06more
Wuhan YZY Biopharma Holds the ...

April 8, 2015 – Wuhan YZY biopharma holds the corner stone laying ceremony for its biopharma manufa...

04-09more